NEXT Oncology /ID# 261601 — San Antonio, Texas

NEXT Oncology /ID# 261601 is a clinical research site located in San Antonio, Texas, United States 78229.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

NEXT Oncology /ID# 261601 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT Oncology /ID# 261601?

NEXT Oncology /ID# 261601 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT Oncology /ID# 261601 conducted?

NEXT Oncology /ID# 261601 has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Castration-Resistant Prostate Cancer.

Is NEXT Oncology /ID# 261601 accredited by Crixeo Health?

NEXT Oncology /ID# 261601 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NEXT Oncology /ID# 261601?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.